Countering Young Adult Tobacco Marketing in Bars
|ClinicalTrials.gov Identifier: NCT01686178|
Recruitment Status : Completed
First Posted : September 17, 2012
Last Update Posted : October 18, 2017
|Condition or disease||Intervention/treatment||Phase|
|Smoking Cessation||Behavioral: Anti-smoking social marketing campaign||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||17422 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Countering Young Adult Tobacco Marketing in Bars|
|Study Start Date :||September 2012|
|Actual Primary Completion Date :||July 2, 2017|
|Actual Study Completion Date :||July 2, 2017|
Experimental: Anti-smoking social marketing campaign
In prior research, a high risk subpopulation of young adults was identified in San Diego, CA: the "hipster" subculture. We developed a yearlong pilot social branding intervention to decrease smoking among this group, using social events and social leaders to promote a strong nonsmoking lifestyle. The intervention rationale is based on utilizing industry market research tools to define the target audience and directly countering tobacco industry lifestyle marketing strategies. We now propose to extend this intervention to three other cities (tailoring the intervention to a high-risk subpopulation of young adults in each city) and evaluate it in a multicenter quasi-experimental controlled trial.
Behavioral: Anti-smoking social marketing campaign
We will utilize industry market research tools to define the target audience (segment of community with high smoking prevalence and high social influence) and directly counter tobacco industry lifestyle marketing strategies through local promotion of a smokefree brand and branded bar and club events.
No Intervention: Control
Survey research data will be collected in control cities with the same schedule as data collection in the cities where the intervention is taking place.
- Self-Reported Tobacco Smoking in past 30 days [ Time Frame: Between baseline and follow-up at 1,2, & 3 years post-baseline ]The main outcome measure for this analysis will be the proportion of current smoking, defined as self-reported smoking on one or more of the past 30 days.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01686178
|United States, California|
|University of California, San Francisco|
|San Francisco, California, United States, 94530|
|Principal Investigator:||Pamela M Ling, MD, MPH||University of California, San Francisco|